Top Markets
Coin of the day
Genomics BioSci & Tech. Co.,Ltd. Genomics BioSci & Tech. Co.,Ltd.

Genomics BioSci & Tech. Co.,Ltd.

4195
株式のランク #26613
Genomics BioSci & Tech. Co.,Ltd. specializes in providing a comprehensive array... Genomics BioSci & Tech. Co.,Ltd. specializes in providing a comprehensive array of services within the field of genomic sequencing. Its core offerings encompass standard and intricate DNA sequencing, including TAF-certified options, with clients also benefiting from complimentary sequencing primer and primer walking services. Beyond sequencing, the company is proficient in synthesizing peptides, genes, and oligonucleotides. Furthermore, its analytical capabilities extend to crucial laboratory services such as sample preparation, gene expression analysis, genotyping, DNA methylation analysis, and microbial identification. The firm also delivers advanced sequencing solutions, including genome-level, targeted, gene regulation, and metagenomic sequencing, alongside cutting-edge third-generation sequencing technologies. To support these services, it offers integrated sequencing platforms and streamlined workflows. Additionally, Genomics BioSci & Tech. Co.,Ltd. provides specialized diagnostic screenings, such as non-invasive prenatal testing (NIPT), spinal muscular atrophy (SMA) carrier screening, and fragile X syndrome premutation screening. Established in 2001, the company's headquarters are located in New Taipei City, Taiwan.
株価
$0.54058348
最終同期: 2026-06-04
時価総額
$39.16M
変化(1日)
2.72%
変化(1年)
-18.72%
TW
取引 Genomics BioSci & Tech. Co.,Ltd. (4195)

カテゴリー

Genomics BioSci & Tech. Co.,Ltd.(4195)の株式分割履歴
Genomics BioSci & Tech. Co.,Ltd.株(シンボル:4195)は合計で0回の株式分割を実施しました。
最新の株式分割はAug 20, 2026に行われました。
Aug 20, 2026より前に購入された4195株は、現在04195株に相当します。
株式分割一覧
株式分割 分割比率 累積分割比率
提供された日付のデータは十分ではありません。
類似企業または競合他社の株式分割
企業 株式分割の回数 累積分割比率
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH